More People Being Fired

Discussion in 'Esperion' started by anonymous, Feb 21, 2021 at 4:30 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    There are plenty of “good reps” who have survived in other environments that really can’t sell. Not bad people, probably good neighbors, but just not good SALESPERSON. Pharma has tons of “good reps” that don’t really know how to sell, it’s really quite comical.
     

  2. anonymous

    anonymous Guest

    BA never was going to sell. Have you done any research ?

    This was set up to make the upper management wealthy, until the useful idiot investors realized.

    And it keeps on.

    Good play Management.
     
  3. anonymous

    anonymous Guest

    Comical are the ass hats they're bringing in to fill open positions. Recruiters won't even touch these holes after they do a little research or get feedback from candidates who do research.
    I guess if you can make $120K for a few months until it catches up, why not?
    People let go after 6 months replaced by new people who have the same performance after 6 months...now what?
     
  4. anonymous

    anonymous Guest

    BA should fly off the shelves, bringing in two well known people from Sanofi will make Esperion a top notch organization. Let’s celebrate
     
  5. anonymous

    anonymous Guest

    Who are the 2 people from Sanofi ?

    The culture is set at Esperion. 2 people will have no impact.

    By the way.

    Were they Scientifically Hired, Highly Tenured Customer Facing soon to be Lipid Experts ?
     
  6. anonymous

    anonymous Guest

    Who is coming in from Sanofi. Sanofi management couldn't hit the floor with their hats. Total morons. They should fit right into Ann Arbor. Will the Scientific Intervew Process be used? Will they steal their business plans and action plans?? Will they get jerked around by a travel agent and told to go to airport and wait for the next interview? Will they be taping and recording the interviews? Will Tim be taking the lead on these Sanofi rejects? Can we count on Tim to use deceit and lying throughout interviews ??
     
  7. anonymous

    anonymous Guest

    Dimwit Dipshit is a sanofi reject who couldn’t get to first base, apparently the air of France was a setback (you smell) and the lying deception didn’t help the cause; now all there is to do is obsessively retort to an audience that doesn’t give a shit. Go wash the trailer.
     
  8. anonymous

    anonymous Guest

    Sheldon is an accomplished leader in the cardiovascular space and brings over 25 years of leadership roles to Esperion. Most recently, he was with chief commercial officer at Portola pharmaceuticals until it was acquired by Alexion. Prior to joining Portola, Sheldon was senior vice president and head of the cardiovascular franchise for Sanofi where he led U.S. business operations and product launches in more than 20 countries.

    Here’s one , find the other
     
  9. anonymous

    anonymous Guest

    Sheldon was a complete joke when he was at Sanofi. He was awful on stage. No vision just a standard corporate cutout that tries to talk a big story. Please don't embarass yourself by posting these things about Sheldon like he's the King Kong of pharma..his career at Sanofi was uneventful. Plavix sold itself along with Lovenox. He's no genius. He's more a Michael Scott from the The Office type of business mind.
     
  10. anonymous

    anonymous Guest

    Experienced leaders from Sanofi will jumpstart and drive new business.
    Most Esperion representatives do not know this fact and how lucky they are to have several Sanofi leaders running segments of the business.
     
  11. anonymous

    anonymous Guest

    Yep the Sanofi leaders are top shelf. Go over to there board and see what management has done there for last 20 years. Sheldon wasn't involved with PCSK9 as his time at Sanofi was Plavix which sold itself, on every plan. NO LIPID EXPERIENCE!!! He's flaccid and weak. If your depending on former Sanofi leaders to right the ship than you just signed BA's death warrant. Nice hire Tim. Another Scientific failure.
     
  12. anonymous

    anonymous Guest

    Agree, Sheldon will not save the day, to be kind, his career at Sanofi was unremarkable. He had nothing to do with the success of Lovenox, nor Plavix. His claim to fame is Praluent, which is really more a claim to infamy, though in fairness this was not all on him. Let's be honest, payers like the status quo in this category and the medical community just doesn't seem willing to advocate for new therapies.
     
  13. anonymous

    anonymous Guest

    From the poster above...1 new management person is going to save the day?

    This sounds like desperation.

    Is this Sheldon a Hail Mary Pass ?
     
  14. anonymous

    anonymous Guest

    He bailed on Praluent. Made numerous bad decisions. Awkward person who has no vision. When things get tough Sheldon will bail quickly.
     
  15. anonymous

    anonymous Guest

    Sheldon could fuckup a glass of water. He's a typical Pharma Stooge who excels at reading teleprompters.
     
  16. anonymous

    anonymous Guest

    Now that prescriptions were flat, we have to wonder what Tim will do next. No way to end the quarter with no weekly growth. This may get uglier soon.
     
  17. anonymous

    anonymous Guest

    Tim will use Covid as the excuse again for the flat numbers. If that doesn't work he'll say it's because Biden tripped on the stairs getting on the plane. Look at the launch record of other companies verses Esperion. It's quite an accomplishment to be dead last in launches of 2020. How does this board not get replaced? How long will investors get deceived??
     
  18. anonymous

    anonymous Guest

    The dismal acceptance BA would receive, was voiced in Feb. ahead of the launch, before most of the Covid stuff started.

    Now it has played out.

    I couldn't go along the totally unprofessional Scientific Hiring Process and saw that the culture would be toxic.
     
  19. anonymous

    anonymous Guest

    Investors are finding their wallets lighter.
    Traders shorting not so.
    Upper managements wallets getting heavier from Investors. Thanks.
     
  20. anonymous

    anonymous Guest

    The scripts are flat this quarter? If flat, what are the weekly volumes up to right now?